170 related articles for article (PubMed ID: 18759457)
1. Structural and functional characterization of human SGT and its interaction with Vpu of the human immunodeficiency virus type 1.
Dutta S; Tan YJ
Biochemistry; 2008 Sep; 47(38):10123-31. PubMed ID: 18759457
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
[TBL] [Abstract][Full Text] [Related]
4. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
[TBL] [Abstract][Full Text] [Related]
5. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T
J Mol Biol; 1994 Feb; 236(1):16-25. PubMed ID: 8107101
[TBL] [Abstract][Full Text] [Related]
6. Structural consequences of phosphorylation of two serine residues in the cytoplasmic domain of HIV-1 VpU.
Wittlich M; Koenig BW; Willbold D
J Pept Sci; 2008 Jul; 14(7):804-10. PubMed ID: 18186541
[TBL] [Abstract][Full Text] [Related]
7. Small glutamine-rich tetratricopeptide repeat-containing protein is composed of three structural units with distinct functions.
Liou ST; Wang C
Arch Biochem Biophys; 2005 Mar; 435(2):253-63. PubMed ID: 15708368
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu).
Henklein P; Schubert U; Kunert O; Klabunde S; Wray V; Klöppel KD; Kiess M; Portsmann T; Schomburg D
Pept Res; 1993; 6(2):79-87. PubMed ID: 8387359
[TBL] [Abstract][Full Text] [Related]
9. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
Lee YH; Schwartz MD; Panganiban AT
Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
[TBL] [Abstract][Full Text] [Related]
10. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
Deora A; Spearman P; Ratner L
Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
Friborg J; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):10-22. PubMed ID: 8548340
[TBL] [Abstract][Full Text] [Related]
13. Exploring the conformational space of Vpu from HIV-1: a versatile adaptable protein.
Krüger J; Fischer WB
J Comput Chem; 2008 Nov; 29(14):2416-24. PubMed ID: 18432615
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
Margottin F; Benichou S; Durand H; Richard V; Liu LX; Gomas E; Benarous R
Virology; 1996 Sep; 223(2):381-6. PubMed ID: 8806575
[TBL] [Abstract][Full Text] [Related]
15. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
[TBL] [Abstract][Full Text] [Related]
16. Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein.
Handley MA; Paddock S; Dall A; Panganiban AT
Virology; 2001 Dec; 291(2):198-207. PubMed ID: 11878889
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family.
Callahan MA; Handley MA; Lee YH; Talbot KJ; Harper JW; Panganiban AT
J Virol; 1998 Jun; 72(6):5189-97. PubMed ID: 9573291
[TBL] [Abstract][Full Text] [Related]
18. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.
Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB
Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605
[TBL] [Abstract][Full Text] [Related]
19. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
20. Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation.
Lemaitre V; Ali R; Kim CG; Watts A; Fischer WB
FEBS Lett; 2004 Apr; 563(1-3):75-81. PubMed ID: 15063726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
